RARA CRAFT DATABASE for FDA Medical Devices

FDA Device Decisions, April 2025: Leadless Left-Ventricular Pacing, Behavioral Therapy Software for Migraine, Four De Novo Grants and Three Original PMAs

日本語版

One of FDA's three original PMA approvals in April 2025 went to the WiSE CRT System (P240028), which paces the heart through a small receiver implanted on the inside wall of the left ventricle, powered by ultrasound from a transmitter under the skin. It is for cardiac resynchronization therapy (CRT) patients in whom a coronary sinus lead could not be placed, or for whom placing one carries high risk.

The other two PMAs were a small-diameter defibrillation lead and a wearable defibrillator worn as a patch on the chest. Among the four De Novo grants were software that delivers behavioral therapy to prevent migraine and a system implanted under the scalp to record brain activity (EEG) continuously.

Counting records held in RA Craft Database (decisions through August 31, 2026, tallied October 6), FDA cleared 281 510(k)s in April 2025, granted 4 De Novo requests and approved 3 original PMAs. These counts have not been reconciled with FDA's own figures. The site holds 510(k), De Novo and PMA records from 2015 onward, and counts for past months can change as the data are updated.

Counts by pathway

April 2025 next to the previous month and the same month a year earlier, with records assigned to a month by FDA decision date.

PathwayApril 2025March 2025April 2024
510(k)281239244
De Novo426
PMA (original)303
PMA supplement187178167

Records held in RA Craft Database, decisions through August 31, 2026.

510(k) clearances were 42 more than in March and above April 2024 (244). There were 4 De Novo grants and 3 original PMAs.

The busiest product codes

April's 510(k)s spread across 188 product codes. GEX (powered laser surgical instrument) and QIH (automated radiological image processing software) led with 8 each, followed by HRS (plate, fixation, bone), IYN (system, imaging, pulsed doppler, ultrasonic), LLZ (system, image processing, radiological) and OLO (orthopedic stereotaxic instrument) with 5 each. A single 510(k) can carry more than one product code, so per-code counts can add up to more than the number of submissions. If your code is on the list, enter it in the Product Code field on Search to see the records sorted by decision date.

De Novo: four classifications

April's four De Novo grants, all Class II, with the classification names and regulation numbers from each Classification Order:

  • Prapela SVS hospital bassinet pad (DEN240031, Prapela, Inc.): Therapeutic vibrational mattress pad (21 CFR 880.5151)
  • Tango Belt (DEN240021, Active Protective Technologies, Inc.): Wearable fall injury prevention device (21 CFR 890.3780)
  • CT-132 (DEN240064, Click Therapeutics, Inc.): Computerized behavioral therapy device for headache (21 CFR 882.5806)
  • Minder System (DEN240062, Epiminder Pty. Ltd.): Sub-scalp implanted electroencephalogram system for remote patient monitoring (21 CFR 882.1360)

"21 CFR" refers to Title 21 of the Code of Federal Regulations, where FDA's regulations are codified.

Prapela SVS is a hospital mattress pad that delivers vibration as adjunctive non-pharmacological therapy for newborns of at least 37 weeks' gestation with neonatal opioid withdrawal syndrome after prenatal opioid exposure. The Tango Belt is worn as an adjunct to standard of care to reduce the risk of hip fracture or hip dislocation from falls in older adults at risk of major hip injury. The Minder System is implanted under the scalp to acquire, transmit and store EEG continuously in patients aged 18 to 75 with drug-resistant epilepsy.

Original PMAs: three approvals

  • WiSE CRT System (P240028, EBR Systems, Inc.): a CRT system that paces the left ventricle from inside without a lead, using ultrasound (product code SEG)
  • OmniaSecure MRI SureScan Lead Model 3930M (P240036, Medtronic, Inc.): a small-diameter defibrillation lead for the right ventricle (NVY)
  • Jewel Patch Wearable Cardioverter Defibrillator (P230022, Element Science, Inc.): a wearable defibrillator applied as a patch on the chest (MVK)

April also brought 187 PMA supplements, which cover changes to already approved PMA devices among other things.

Three devices worth a closer read

1. WiSE CRT System (P240028, PMA). A transmitter implanted under the skin sends ultrasound to a receiver fixed to the left ventricular endocardium, which converts it into pacing pulses in sync with a co-implanted right ventricular pacing system. It is for patients 22 and older in whom a coronary sinus lead implant was attempted and abandoned, whose left ventricular lead no longer works, or for whom a standard CRT upgrade is not advisable because of risks such as venous occlusion or infection. According to the Summary of Safety and Effectiveness Data (SSED) that FDA published with the approval, it received Breakthrough Device designation in 2019. The conditions of approval include a post-approval study of about 320 patients followed for five years.

2. CT-132 (DEN240064, De Novo). Prescription software for the preventive treatment of episodic migraine in patients 18 and older, used alongside acute and other preventive treatments. There are only three special controls: clinical performance testing that validates the behavioral therapy model, software specifications and verification, and labeling. The labeling must warn that the device is not a standalone therapy and does not substitute for the patient's medication. The Classification Order says nothing about AI or machine learning.

3. Jewel Patch Wearable Cardioverter Defibrillator (P230022, PMA). Worn on the chest by adults at risk of sudden cardiac arrest who are not candidates for, or refuse, an implantable defibrillator. It monitors the heart rhythm continuously and delivers a shock when it detects ventricular tachycardia or fibrillation (VT/VF). According to the SSED, detection uses a machine learning-based model, and the post-approval study will evaluate that detector on at least 200 VT/VF events. In the 305-patient pivotal study, inappropriate shocks occurred at 0.357 per 100 patient-months.

Compare the three devices

Open P240028, DEN240064 and P230022, star (☆) each one, tick "Compare" on all three in My Workspace and press "3 selected for comparison". The comparison table puts their Indications for Use side by side. Before relying on any of this, open "FDA Record" and "Summary PDF" on each record and read the source.

Note: months are assigned by FDA decision date, and counts can change as the data are updated each month.

RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.

← All articles